Clinical trial
Host Response to Infection and Treatment in Filarial Diseases
NCT00001230 · National Institute of Allergy and Infectious Diseases (NIAID), NIH · Recruiting
Key facts
| NCT number | NCT00001230 |
|---|---|
| Title | Host Response to Infection and Treatment in Filarial Diseases |
| Official title | Host Response to Infection and Treatment in the Filarial Diseases of Humans |
| Lead sponsor | National Institute of Allergy and Infectious Diseases (NIAID), NIH |
| Status | Recruiting |
| Study type | Observational |
| Conditions | Filariasis, Helminthiasis, Parasitic Infection, Mansonelliasis, Onchocerciasis |
| Intervention type | Drug |
| Interventions | Diethylcarbamazine |
| Enrollment | 500 |
| Start date | Mar 15, 1991 |
| First posted | Nov 4, 1999 |
| Last update posted | Jan 28, 2026 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: